ASX 300

Copper’s strong run in face of trade wars piques investor interest in stocks such as Develop, discovery runaway AusQuest, Coda and Noronex.

Traders are waiting for weeks to withdraw gold in London, as demand for physical gold ramps up to several new factors.

First Sentier's David Wilson and Elston's Joe McCarthy pick apart companies with strong sales growth - is it all it's cracked up to be?

With gold surging to record highs and many investors expecting the run to continue, are you holding gold in your portfolio?

The fundamentals for uranium appear strong, growing demand from nuclear power and AI versus limited scope for production increases.

How should investors interpret Trump’s tariff threats—literally, seriously, neither, or both?

Corporate Australia has battled (too) many headwinds over the past three years, but investor optimism is on the rise for better times ahead.

BNPL has its roots in the 19th century, originating from instalment plans that allowed consumers to purchase expensive items like furniture and farm equipment by...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future...

ASX-listed Brazilian Rare Earths is widely considered a potential takeover target as fund manager Regal builds a position on the register.

'Cloning' top fund managers can be a winning strategy. Check out 3 ASX growth stocks that are worth a further look.

Just when you thought the bitcoin frenzy couldn't get more bizarre, AMP announced it's jumped in on behalf of its super investors.

Elston's Joe McCarthy and First Sentier's David Wilson share their tips for hunting great growth stocks, and an example for good measure

Amid the DeepSeek-induced selloff, REITs were amongst the better performing sectors. But what will the developments mean for data centres?

Could this Australian-American healthcare stalwart hit $60/share?

We think that Perpetual should keep its crown jewel - its corporate trust business.

Joe McCarthy from Elston and David Wilson from First Sentier run the ruler over your most-tipped growth stocks for 2025

The transformational merger of Chemist Warehouse Group and Sigma Healthcare has cleared the final hurdles, with both Sigma and Chemist Warehouse shareholders voting to...

We discuss our stock picks from 2024 and then highlight three new high-quality companies best placed to navigate 2025.

Pilbara Minerals shares are rallying on a better-than-expected quarterly production and activities report, we investigate why.

Centennial Asset Management's Matt Kidman says an 'active' investment strategy will continue to beat the market.

In this analysis piece, we examine whether DeepSeek's news is a blip or a game-changer for the ultra-bull market in mega-cap tech.

Investors dumped their tech stocks overnight, with Nvidia down a staggering ~US$500 billion in market cap. Are local tech names in trouble?

Rudi Filapek-Vandyck, Michael Wayne, and Henry Jennings each boldly nominate the one ASX stock they believe will hit $500 first.